33 results - M - W - D

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

9/30/24 19:12
9/27/24
VRDNHealthHealthMedical LaboratoriesBeetham Thomas W.MAOCOOP11723.41055006D
9/30/24 19:10
9/27/24
VRDNHealthHealthMedical LaboratoriesMahoney Stephen F.MADOP,CEOP49923.33021New21D
9/17/24 21:00
9/13/24
VRDNHealthHealthMedical LaboratoriesFairmount Funds Management LLCPADTP30,00018.7501,600873,446I
1/24/24 18:44
1/22/24
VRDNHealthHealthMedical LaboratoriesFairmount Funds Management LLCPADTHSee RemaP10,00021.000476351,846I
6/20/23 17:23
6/15/23
VRDNHealthHealthMedical LaboratoriesMeisner LaraMAOGCM.dm5323.0302830D
6/20/23 17:23
6/15/23
VRDNHealthHealthMedical LaboratoriesMeisner LaraMAOGCS.dm-6428.020-2-730D
6/6/23 19:41
6/2/23
VRDNHealthHealthMedical LaboratoriesMeisner LaraMAOGCM.dm13017.38083330D
6/6/23 19:41
6/2/23
VRDNHealthHealthMedical LaboratoriesMeisner LaraMAOGCS.dm-18624.820-8-2030D
4/12/23 19:05
4/12/23
VRDNHealthHealthMedical LaboratoriesMyers Scott DunsethMADOCEOP10125.37042260D
3/13/23 16:06
3/13/23
VRDNHealthHealthMedical LaboratoriesMyers Scott DunsethMADOCEOP16029.15062256D
3/10/23 16:05
3/9/23
VRDNHealthHealthMedical LaboratoriesMeisner LaraMAOGC,SecreS-87129.070-30-1000D
2/7/23 18:35
2/2/23
VRDNHealthHealthMedical LaboratoriesViolin JonathanMADOChief EM.ad80.150005012481D
2/7/23 18:35
2/2/23
VRDNHealthHealthMedical LaboratoriesViolin JonathanMADOChief ES.ad-1,84036.800-50-9481D
2/3/23 18:12
2/2/23
VRDNHealthHealthMedical LaboratoriesViolin JonathanMADOChief ES-1,84036.800-50-10431D
1/25/23 18:04
1/23/23
VRDNHealthHealthMedical LaboratoriesMeisner LaraMAOGC,SecreM.d14120.56070D
1/25/23 18:04
1/23/23
VRDNHealthHealthMedical LaboratoriesMeisner LaraMAOGC,SecreS.d-24435.660-7-1000D
1/18/23 17:58
1/13/23
VRDNHealthHealthMedical LaboratoriesKatz BarrettMAOChief MeM.dm66823.030290D
1/18/23 17:58
1/13/23
VRDNHealthHealthMedical LaboratoriesKatz BarrettMAOChief MeS.dm-1,07837.180-29-1000D
1/11/23 19:09
1/9/23
VRDNHealthHealthMedical LaboratoriesKatz BarrettMAOChief MeM.dm1,38223.030600D
1/11/23 19:09
1/9/23
VRDNHealthHealthMedical LaboratoriesKatz BarrettMAOChief MeS.dm-2,08934.820-60-1000D
12/22/22 16:42
12/20/22
VRDNHealthHealthMedical LaboratoriesMeisner LaraMAOGC,SecreM.dm39023.030170D
12/22/22 16:42
12/20/22
VRDNHealthHealthMedical LaboratoriesMeisner LaraMAOGC,SecreS.dm-49329.150-17-1000D
12/19/22 19:22
12/15/22
VRDNHealthHealthMedical LaboratoriesMeisner LaraMAOGC,SecreM.dm3723.03020D
12/19/22 19:22
12/15/22
VRDNHealthHealthMedical LaboratoriesMeisner LaraMAOGC,SecreS.dm-4528.370-2-1000D
12/14/22 20:56
12/12/22
VRDNHealthHealthMedical LaboratoriesMeisner LaraMAOGC,SecreM.dm37423.030160D
12/14/22 20:56
12/12/22
VRDNHealthHealthMedical LaboratoriesMeisner LaraMAOGC,SecreS.dm-45728.120-16-1000D
11/16/22 18:45
11/15/22
VRDNHealthHealthMedical LaboratoriesMeisner LaraMAOGC,SecreM.d11414.00080D
11/16/22 18:45
11/15/22
VRDNHealthHealthMedical LaboratoriesMeisner LaraMAOGC,SecreS.d-17922.050-8-1000D
8/19/22 16:32
8/17/22
VRDNHealthHealthMedical LaboratoriesFairmount Funds Management LLCPADTHSee RemaP10,00023.500426451,370I
6/2/22 17:29
6/1/22
VRDNHealthHealthMedical LaboratoriesViolin JonathanMADOChief ES-36612.200-30-6481D
5/4/22 17:23
5/2/22
VRDNHealthHealthMedical LaboratoriesViolin JonathanMADOCEOS-39113.040-30-6511D
4/5/22 18:09
4/1/22
VRDNHealthHealthMedical LaboratoriesViolin JonathanMADOChief ES.m-56818.920-30-5541D
3/3/22 16:48
3/1/22
VRDNHealthHealthMedical LaboratoriesViolin JonathanMADOChief ES.m-52917.650-30-5571D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact